Biomycin-M (Amoxicillin trihydrate, Neomycin sulfate) syringe tube 5 ml * 4 pcs

Suspension for intramammary use.

Composition

Contained in 1 ml:

• Amoxicillin trihydrate: 100 mg.
• Neomycin sulfate: 50 mg.
• Solvent: 1 ml.

Pharmacological properties

The combination of amoxicillin and neomycin has an additive effect. Amoxicillin is a semi-synthetic penicillin with a broad spectrum of action with bactericidal action against gram-positive and gram-negative bacteria. It affects Campylobacter, Clostridium, Corynebacterium, Escherichia coli, Erysipelothrix, Hemoglobinophilic bacteria, Pasteurella, Salmonella, Streptococcus and penicillinase-negative staphylococci. Bactericidal action is expressed in inhibition of synthesis of a cellular cover of bacteria. Neomycin is an aminoglycoside that has bactericidal activity against mainly gram-negative bacteria such as Escherichia coli, Klebsiella, Pasteurella, Salmonella and staphylococci.

Indication

Treatment of clinical mastitis caused by microorganisms sensitive to amoxicillin and neomycin, such as corynebacteria, Escherichia coli, staphylococci and streptococci.

Dosage

For intramammary use:

Daily 1 injector on the affected part of the udder for a maximum of 3 days.

Before use, completely remove the udder, clean and disinfect the nipples.

Contraindication

• Hypersensitivity to amoxicillin and / or neomycin.
• Use in subtherapeutic doses.
• Co-administration with tetracyclines, chloramphenicols, macrolides and lincosamides.
• Administration to animals with severe renal and / or hepatic impairment.
• Overdose due to a very small safe limit in neomycin.

Side effects:

• Allergic reactions.
• Renal dysfunction, neurotoxicity and neuromuscular blockade.

Withdrawal time of the drug:

• For meat: 5 days.
• For milk: 3 days.

Warning:

Keep out of reach of children.

Package:

Injector 5 ml.